您当前的位置:
首页 >
文章列表页 >
In vivo and in vitro studies on geniposide suppressing malignant progression of glioblastoma by enhancing miR-376b-3p A-to-I editing to inhibit glycolysis
Article | 更新时间:2026-06-22
    • In vivo and in vitro studies on geniposide suppressing malignant progression of glioblastoma by enhancing miR-376b-3p A-to-I editing to inhibit glycolysis

    • Chin Oncol   Vol. 36, Issue 5, Pages: 436-448(2026)
    • DOI:10.19401/j.cnki.1007-3639.2026.05.002    

      CLC: R739.41
    • Received:27 October 2025,

      Revised:2025-12-25,

      Published:30 May 2026

    移动端阅览

  • WU S C, WANG B, WEI Z X, et al. In vivo and in vitro studies on geniposide suppressing malignant progression of glioblastoma by enhancing miR-376b-3p A-to-I editing to inhibit glycolysis[J]. Chin Oncol, 2026, 36(5): 436-448. DOI: 10.19401/j.cnki.1007-3639.2026.05.002.

  •  
  •  

0

Views

7

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

TCF7 transcriptional activation of MACC1 regulates aerobic glycolysis and promotes oxaliplatin resistance in rectal cancer
Research progress of hypoxia-induced mitochondrial autophagy and glucose metabolism reprogramming in gastric precancerous lesions
ZDHHC12 regulates tumor properties through YAP1 in glioblastoma
New strategies for combined with immunotherapy of clear cell renal cell carcinoma: advances in aerobic glycolysis
CircSMARCA5 inhibits glycolysis and suppresses proliferation and invasion of gastric cancer cells through miR-4295/PTEN axis

Related Author

Tingting MA
Jianhong XIA
Liqing ZHOU
Yan YAN
Yongxue ZHOU
Jiaxiang ZHANG
Shuguang YAN
Weihan ZHAO

Related Institution

Radiotherapy Department, The Second People's Hospital of Huai'an, The Affiliated Huai’an Hospital of Xuzhou Medical University
School of Basic Medicine, Shaanxi University of Traditional Chinese Medicine
Department of Gastroenterology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Department of Oncology, Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University
0